ArticleBreast cancer (Tokyo, Japan)2026
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer.
Miharu Kano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.